US Stock MarketDetailed Quotes
VYGR Voyager Therapeutics
- 6.860
- +1.080+18.69%
Close Nov 29 13:00 ET
- 6.890
- +0.030+0.43%
Post 17:01 ET
374.73MMarket Cap10.39P/E (TTM)
7.030High6.266Low1.19MVolume6.270Open5.780Pre Close8.06MTurnover2.65%Turnover Ratio2.31P/E (Static)54.63MShares11.72052wk High1.13P/B308.04MFloat Cap5.19052wk Low--Dividend TTM44.90MShs Float31.910Historical High--Div YieldTTM13.22%Amplitude2.460Historical Low6.775Avg Price1Lot Size
About Voyager Therapeutics Company
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.
Company Profile
SymbolVYGR
Company NameVoyager Therapeutics
Listing DateNov 11, 2015
Issue Price14.00
Founded2013
CEODr. Alfred W. Sandrock, Jr,M.D.,PhD
MarketNASDAQ
Employees162
Fiscal Year Ends12-31
Address75 Hayden Avenue
CityLexington
ProvinceMassachusetts
CountryUnited States of America
Zip Code02421
Phone1-857-259-5340
Company Executives
- Name
- Position
- Salary
- Dr. Alfred W. Sandrock, Jr,M.D.,PhD
- Director, President and Chief Executive Officer
- 3.17M
- Toby Ferguson
- Chief Medical Officer
- --
- Robin Swartz
- Chief Operating Officer
- 1.38M
- Dr. Nathan Jorgensen, M.B.A.,PhD
- Chief Financial Officer and Principal Accounting Officer
- --
- Jacquelyn Fahey Sandell, J.D.
- Chief Legal Officer
- 1.68M
- Dr. Todd Carter, PhD
- Chief Scientific Officer
- --
- Michael J. Higgins
- Chairman of the Board
- 281.28K
- Dr. Jude Onyia, PhD
- Director
- 452.32K
- Dr. Glenn F. Pierce, M.D.,PhD
- Independent Director
- 248.78K
- Dr. Grace E. Colon, PhD
- Independent Director
- 432.23K
- Nancy Vitale
- Independent Director
- 255.28K
- Dr. Catherine J. Mackey, PhD
- Independent Director
- 250.78K
- James A. Geraghty
- Independent Director
- 263.78K
- Dr. George A. Scangos,PhD
- Independent Director
- 559.79K
- Dr. Steven E. Hyman, M.D.
- Independent Director
- 255.78K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
